Srishti Khurana

Live biotherapeutics are fragile bacteria, which require ideal conditions of heat, moisture and pH of products, to survive and prevent premature germination. In fact, manufacturing is presently one of...

In the pharmaceutical industry, stakeholders are known to adopt a variety partnerships and expansion models. Such initiatives not only allow the companies to expand their respective product / service...

Prefilled syringes have been in market for over two decades now and have witness significant growth in terms of both adoption and revenues. The biopharmaceutical industry, given the fact that...

Given the multifaceted advantages of large volume wearable injectors, the field has witnessed an increase in the number of players involved in the development of such devices. The domain features the...

Over the past few years, there has been an evident shift towards the self-administration of drugs / therapies. This is largely attributed to the several limitations associated with the conventional...

Currently, three drug-device combinations, namely Herceptin® SC Injector (Roche), Neulasta® (pegfilgrastim) OnPro™ Kit (Amgen / Insulet) and Repatha® Pushtronex™ System (Amgen / West Pharmaceutical...

Numerous scientific and technological breakthroughs in the medical device industry, over the past decade, have resulted in an accelerated pace of research and innovation within this domain. Further...

According to experts in the healthcare industry, one in three adults are estimated to be suffering from some type of chronic clinical condition, such as multiple sclerosis, diabetes, rheumatoid...

Neoantigen Targeted Therapies Pave the Way to Personalized Anti-cancer TherapyThere is an urgent unmet need for developing innovative and effective cancer therapeutics for the treatment of patients...

In the pharmaceutical industry, stakeholders are known to adopt a variety partnerships and expansion models. Such initiatives not only allow the companies to expand their respective product / service...

Globally, the oligonucleotide manufacturers are focusing on research and diagnostic, and therapeutic applications. As per the analysis, more than 25 companies provide manufacturing services for...

At present, eight oligonucleotide-based drugs have been approved, while over 200 product candidates are being evaluated in various clinical trials across the globe. As the market for such therapeutic...

During our research, we were able to identify over 250 industry players that presently claim to offer contract services for clinical development of medical devices. In addition, there are more than 40...

The pharmaceutical industry witnessed a gradual increase in the adoption of autoinjectors for drug delivery. These devices can be designed / modified to cater to drug specific administration...

Competitive benchmark analysis allows the companies to compare their existing capabilities within their respective peer groups (based on company size and location of headquarters) and thereby...